Global Paracetamol IV Market to reach USD 1,575.45 million by 2030 - By Indication (Pain, Pyrexia/Fever), Application (Non-surgical, Surgical), End-use - Forecast 2024-2030

Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global Paracetamol IV Market by Indication (Pain, Pyrexia/Fever), Application (Non-surgical, Surgical), End-use - Forecast 2024-2030" report has been added to's offering.

The Paracetamol IV Market size was estimated at USD 940.79 million in 2023, USD 1,008.13 million in 2024, and is expected to grow at a CAGR of 7.64% to reach USD 1,575.45 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Paracetamol IV Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Paracetamol IV Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

Key Attributes

Report AttributeDetails
No. of Pages194
Forecast Period2024 - 2030
Estimated Market Value (USD) in 2024$1 Billion
Forecasted Market Value (USD) by 2030$1.57 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal

Companies Mentione

  • Aurobindo Pharma Ltd.
  • Biological E. Limited
  • Cfl Pharmaceuticals Limited
  • Changshu Huagang Pharmaceuticals Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Geno Pharmaceuticals Private Limited
  • Hebei Jiheng Pharmaceutical Co.,Ltd.
  • Huzhou Konch Pharmaceutical Co., Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Mallinckrodt PLC
  • Novartis AG
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Zhejiang Kangle Pharmaceutical Co., Ltd.

Key Topics Covered

  1. Preface:
    • Objectives of the study
    • Market segmentation & coverage
    • Years considered for the study
    • Currency & pricing
    • Language
    • Limitations
    • Assumptions
    • Stakeholders
  2. Research Methodology:
    • Research objectives
    • Research design
    • Research instrument
    • Data source
    • Data interpretation
    • Data verification
    • Research report publication
    • Report update
  3. Executive Summary
  4. Market Overview:
    • Introduction
    • Market overview by region
  5. Market Insights:
    • Market dynamics (drivers, restraints, opportunities, challenges)
    • Market segmentation analysis
    • Market trend analysis
    • Cumulative impact of high inflation
    • Porter's Five Forces Analysis
    • Value chain & critical path analysis
    • Regulatory framework
  6. Paracetamol IV Market, by Indication:
    • Introduction
    • Segmentation by indication (pain, pyrexia/fever)
  7. Paracetamol IV Market, by Application:
    • Introduction
    • Segmentation by application (non-surgical, surgical)
  8. Paracetamol IV Market, by End-use:
    • Introduction
    • Segmentation by end-use (clinics, hospitals)
  9. Americas Paracetamol IV Market:
    • Introduction
    • Market analysis by country (Argentina, Brazil, Canada, Mexico, United States)
  10. Asia-Pacific Paracetamol IV Market:
    • Introduction
    • Market analysis by country (Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
  11. Europe, Middle East & Africa Paracetamol IV Market:
    • Introduction
    • Market analysis by country (Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom)
  12. Competitive Landscape:
    • FPNV positioning matrix
    • Market share analysis by key player
    • Competitive scenario analysis by key player
  13. Competitive Portfolio:
    • Key company profiles
    • Key product portfolio
  14. Appendix:
    • Discussion guide
    • License & pricing

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Paracetamol IV Market

Contact Data